Nutri Pharma products target major lifestyle related diseases involved in the Metabolic Syndrome, which is linked to coronary heart disease. Nutri Pharma, based in Oslo, Norway, was founded by Dr. Lars Høie, M.D., Ph.D. and Trond Syvertsen (M.B.A.) in 1993. NutriPharma aims to be one of the global leaders in functional foods for treatment and prevention of lifestyle-related diseases. Nutri Pharma is a commercially focused R&D organization. The majority of activities are either contracted out, or carried out in collaboration with partners. Nutri Pharma is operating with a small staff covering all key competencies. Key activities, including research and product development are carried out with highly competent and acknowledged external partners. Nutri Pharma products and brands are marketed through carefully selected leaders in the food and pharma sector.